The Centers for Medicare & Medicaid Services late today released guidance on how it will implement its August interim final rule that makes collecting and reporting COVID-19 data a condition of participation for hospitals that participate in Medicare. The guidance includes new reporting requirements for hospitals, as well as enforcement provisions. Highlights of the guidance include:

  • the reduction of mandatory supply-related data reports to once-per-week submissions;
  • a requirement that psychiatric and rehabilitation hospitals report data only once per week;
  • beginning on Nov. 1, Remdesivir- and staffing-related data will be optional; and
  • additional reporting requirements that begin Nov. 1 for certain data on influenza patients.

CMS also describes the enforcement process, which will include initial letters notifying non-compliant hospitals. The initial letters for non-compliance will start going out tomorrow and be followed by warning letters beginning three weeks after initial notifications.

Hospitals that remain noncompliant will then receive a letter letting them know they will be terminated from the Medicare program unless they come into compliance within 30 days.

Related News Articles

Headline
The Medicare Payment Advisory Commission Dec. 4 and 5 discussed draft payment update recommendations for 2027, which the commission will vote on in January.…
Headline
The House Dec. 1 passed the Hospital Inpatient Services Modernization Act (H.R. 4313), legislation extending certain Medicare waivers authorizing the hospital-…
Headline
The AHA provided recommendations to the Food and Drug Administration Dec. 1 in response to a request for information on the measurement and evaluation of…
Headline
The Centers for Medicare & Medicaid Services announced Dec. 1 that it intends to expand the Inpatient Rehabilitation Facility Review Choice Demonstration…
Headline
The Food and Drug Administration has identified a Class I recall of Baxter Life2000 Ventilation Systems due to a cybersecurity issue discovered through…
Headline
The Centers for Medicare & Medicaid Services Nov. 25 announced lower prices for 15 Medicare Part D drugs selected for the second cycle of negotiations…